CBD-Rich Cannabis Extract Outperformed Pure CBD Against Brain Inflammation in Mice

At 20 mg/kg, CBD-rich cannabis extract was more effective than synthetic CBD in reducing LPS-induced anxiety-like behavior, cognitive deficits, and locomotor impairments in mice. The extract reduced oxidative stress (increased GSH, reduced TBARs), suppressed inflammatory cytokines (IL-6, TNF-alpha) and GFAP, modulated CB1 receptor expression, and preserved astrocyte metabolic homeostasis.

LPS-induced neuroinflammation mouse model. Behavioral tests (open field, elevated plus maze, novel object recognition, Morris water maze), antioxidant assays, RT-PCR for cytokines, and astrocytic bioenergetic analysis via extracellular flux assays. Computational modeling of CB1 receptor interactions.

The finding that a whole cannabis extract outperformed pure CBD supports the "entourage effect" hypothesis and has implications for whether patients should use CBD isolates or full-spectrum products.

The entourage effect remains one of the most debated concepts in cannabis science. Preclinical evidence like this, showing that minor cannabinoids and terpenes in whole extracts may enhance CBD activity, adds to a growing body of work that could reshape how cannabis medicines are formulated.

Mouse model of neuroinflammation may not translate to human neurodegenerative diseases. The extract contains multiple compounds, making it difficult to identify which are responsible for enhanced effects. Computational modeling does not confirm in vivo binding dynamics.